Sito in Italia dove è possibile acquistare la consegna acquisto Viagra a buon mercato e di alta qualità in ogni parte del mondo.

Fvsu.edu

HEALTH and MENTAL HEALTH
____________________________________________________________

TITLE: NLM Administrative Supplements for Informationist Services in

NIH-funded Research Projects (Admin Supp)
AGENCY: U.S. Department of Health and Human Services (HHS); National Institutes of Health (NIH); National Institute on Aging (NIA) ITEM: Notice announcing an Administrative Supplement opportunity available to eligible NIH awardees with active R01 grants and, in some cases, with active P01, P20, P30, P50, R21, R21/R33, R24, R34, U01, U19, U24, U54 and UM1 grants. These administrative supplements provide funds to supported research and center grants in order to enhance the storage, organization, management and use of electronic research data through the involvement of informationists, also known as in-context information ACTION: Applications are due November 5, 2013. Approximately five awards are expected. Eligible NIH awardees include those with active R01 grants and, in some cases, with active P01, P20, P30, P50, R21, R21/R33, R24, R34, U01, U19, U24, U54 and LIMITED SUBMISSION: Only one application per parent award is allowed. CONTACT: Alan VanBiervliet, 301/594-4882. Email: ____________________________________________________________
TITLE: Predictive Methods for Characterizing Product Performance in
Pediatric Patients, Case Study: Furosemide
AGENCY: U.S. Department of Health and Human Services (HHS); Food and Drug ITEM: Notice seeking applications for research projects to test the suitability of the in vitro methods using dissolution media containing milk, baby formula and Ensure Plus for predicting in vivo performance of furosemide (a poorly soluble and poorly permeable drug), classified as BCS (Biopharmaceutic Classification System) Class IV drug. ACTION: Letters of intent are requested and due August 8, 2013. Applications are due August 15, 2013. Approximately $250,000 is available to support three awards.
LIMITED SUBMISSION: Only one application per institution is allowed.
CONTACT: Arzu Selen, 301/796-1603. Email: ____________________________________________________________
TITLE: Support of NIGMS Program Project Grants (P01)
AGENCY: U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) ITEM: Notice seeking innovative, interactive applications that propose to conduct research which aims to solve a significant biological problem, important for the mission of NIGMS, through a collaborative approach involving outstanding scientists. NIGMS supports research in the broad areas of Cell Biology and Biophysics; Genetics and Developmental Biology; Pharmacology, Physiology, and Biological Chemistry; and Bioinformatics and Computational Biology. The Program Project grant is designed to support research in which the funding of several interdependent projects offers significant scientific advantages over support of these same projects as individual ACTION: Applications are due January 25, May 25, and September 25 annually. ____________________________________________________________
TITLE: Clinical Trials in Organ Transplantation (CTOT) (U01)
AGENCY: U.S. Department of Health and Human Services (HHS); National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) ITEM: Notice seeking applications from groups of two or more institutions to participate in a clinical studies program to improve the long-term outcome of transplant recipients (thoracic organ, abdominal organ and vascular composite tissue). The Clinical Trials in Organ Transplantation (CTOT) program will support a cooperative, multi- institutional consortium for the conduct of interventional trials (Phase 1, 2, or 3) or observational clinical studies in organ or vascularized composite allotransplantation (VCA). Each clinical study must include associated mechanistic studies that focus on immune-mediated pathologic processes in allotransplantation or on mechanisms of ACTION: Letters of intent are requested and due October 19, 2013. Applications are due November 19, 2013. Approximately $9.5 million is available to support three to four CONTACT: Nancy Bridges, 301/451-4406. Email: ____________________________________________________________
TITLE: NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)
AGENCY: U.S. Department of Health and Human Services (HHS); National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS) ITEM: Notice seeking applications to provide a vehicle for submitting grant applications to conduct multi-site, randomized, controlled, Phase 3 clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). ACTION: Applications are due February 5, June 5, and October 5 annually. CONTACT: Wendy Galpern, 301/496-9135. Email: ____________________________________________________________
TITLE: NIMHD Social, Behavioral, Health Services, and Policy Research on
Minority Health and Health Disparities (R01)
AGENCY: U.S. Department of Health and Human Services (HHS); National Institutes of Health (NIH); National Institute on Minority Health and Health Disparities (NIMHD) ITEM: Notice seeking applications to solicit innovative social, behavioral, health services, and policy research that can directly and demonstrably contribute to the elimination of health disparities. Projects may involve primary data collection or secondary analysis of existing datasets. ACTION: Letters of intent are requested and due October 19, 2013. Applications are due November 19, 2013. Approximately $3 million is available to support seven to nine CONTACT: Jennifer Alvidrez, 301/594-9567. Email: ____________________________________________________________
TITLE: Centers of Excellence for Big Data Computing in the Biomedical
Sciences (U54)

FON: RFA-HG-13-009
AGENCY: U.S. Department of Health and Human Services (HHS); National Institutes of ITEM: Notice seeking applications to conduct research to advance the science and utility of Big Data in the context of biomedical and behavioral research, and to create innovative new approaches, methods, software, tools, and related resources. The Centers will advance the ability of the biomedical research enterprise to use Big Data by producing tools and resources from early-stage to mature development that will be broadly useful to the research community. ACTION: Letters of intent are requested and due October 20, 2013. Applications are due November 20, 2013. Approximately up to $24 million is available to support six to eight CONTACT: Peter Lyster, 301/594-3928. Email:

Source: http://www.fvsu.edu/files/mainfiles/uploads/8_2_13_HEALTH_and_MENTAL_HEALTH.pdf

Microsoft word - miralax and bisacodyl.doc

Marin Gastroenterology 1350 S. Eliseo Drive, Suite130, Greenbrae, CA 94904 (415) 925-6900 Fax (415) 925-6919 www.MarinGastro.com COLONOSCOPY PREPARATION USING MIRALAX, GATORADE, & BISACODYL Follow the steps below to make sure that your colon is completely clean before your colonoscopy. Call the office if you have questions. Read Immediately: • At the pharmacy, purc

Emergency contacts

Please complete and return to: Director of Programs 152 Madison Avenue, Suite 2400 New York, NY 10016 PHYSICIAN'S EXAMINATION FORM Must be completed by a Physician Name: ________________________________________ Date of Birth (month/date/year): ________________ Sex (M/F): ________ Height: __________ Weight: _________ Blood Pressure: _____________ Date of exam (month/date

Copyright © 2010-2014 Medicament Inoculation Pdf